Eagle Pharmaceuticals, Inc.
FORMULATIONS OF BENDAMUSTINE
Last updated:
Abstract:
Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed. The methods conveniently allow shorter administration time without the active ingredient coming out of solution as compared to presently available formulations.
Status:
Application
Type:
Utility
Filling date:
10 May 2022
Issue date:
25 Aug 2022